New clinical trial platform launched to accelerate COVID-19 treatments
AGILE is a ‘proof of confidence engine’ designed to quickly identify the most promising compounds for treatment of COVID-19
Read More
Tag: Liverpool School of Tropical Medicine and Southampton Clinical Trials Unit
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
